PR Newswire
Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen
📈
AI Sentiment
Highly Positive
8/10
Atossa Therapeutics Inc. News
Latest updates and market news for ATOS
1 news
Dec 7 - Dec 13, 2025
Page 1
Share this news page